{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:06:28Z","timestamp":1767182788517,"version":"3.37.3"},"reference-count":57,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2023]]},"abstract":"<jats:p xml:lang=\"fr\">&lt;abstract&gt;\n &lt;p&gt;Complete spontaneous tumor regression (without treatment) is well documented to occur in animals and humans as epidemiological analysis show, whereby the malignancy is permanently eliminated. We have developed a novel computational systems biology model for this unique phenomenon to furnish insight into the possibility of therapeutically replicating such regression processes on tumors clinically, without toxic side effects. We have formulated oncological informatics approach using cell-kinetics coupled differential equations while protecting normal tissue. We investigated three main tumor-lysis components: (\u2170) DNA blockade factors, (\u2171) Interleukin-2 (IL-2), and (\u2172) Cytotoxic T-cells (CD8&lt;sup&gt;+&lt;\/sup&gt; T). We studied the temporal variations of these factors, utilizing preclinical experimental investigations on malignant tumors, using mammalian melanoma microarray and histiocytoma immunochemical assessment. We found that permanent tumor regression can occur by: 1) Negative-Bias shift in population trajectory of tumor cells, eradicating them under first-order asymptotic kinetics, and 2) Temporal alteration in the three antitumor components (DNA replication-blockade, Antitumor T-lymphocyte, IL-2), which are respectively characterized by the following patterns: (a) Unimodal Inverted-U function, (b) Bimodal M-function, (c) Stationary-step function. These provide a time-wise orchestrated tri-phasic cytotoxic profile. We have also elucidated gene-expression levels corresponding to the above three components: (\u2170) DNA-damage G2\/M checkpoint regulation [genes: &lt;italic&gt;CDC2-CHEK&lt;\/italic&gt;], (\u2171) Chemokine signaling: IL-2\/15 [genes: &lt;italic&gt;IL2RG-IKT3&lt;\/italic&gt;], (\u2172) T-lymphocyte signaling (genes: &lt;italic&gt;TRGV5-CD28&lt;\/italic&gt;). All three components quantitatively followed the same activation profiles predicted by our computational model (Smirnov-Kolmogorov statistical test satisfied, &lt;italic&gt;\u03b1&lt;\/italic&gt; = 5%). We have shown that the genes &lt;italic&gt;CASP7-GZMB&lt;\/italic&gt; are signatures of Negative-bias dynamics, enabling eradication of the residual tumor. Using the negative-biasing principle, we have furnished the dose-time profile of equivalent therapeutic agents (DNA-alkylator, IL-2, T-cell input) so that melanoma tumor may therapeutically undergo permanent extinction by replicating the spontaneous tumor regression dynamics.&lt;\/p&gt;\n &lt;\/abstract&gt;<\/jats:p>","DOI":"10.3934\/mbe.2023420","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T10:45:29Z","timestamp":1679395529000},"page":"9572-9606","source":"Crossref","is-referenced-by-count":3,"title":["Computational systems biology approach for permanent tumor elimination and normal tissue protection using negative biasing: Experimental validation in malignant melanoma as case study"],"prefix":"10.3934","volume":"20","author":[{"given":"Bindu","family":"Kumari","sequence":"first","affiliation":[{"name":"School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi 221005, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrashekhar","family":"Sakode","sequence":"additional","affiliation":[{"name":"Department of Applied Sciences, Indian Institute of Information Technology, Nagpur 44005, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghavendran","family":"Lakshminarayanan","sequence":"additional","affiliation":[{"name":"School of Computational Sciences, Jawaharlal Nehru University, New Delhi 110067, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasun K.","family":"Roy","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi 221005, India"},{"name":"Department of Life Sciences, Shiv Nadar University (SNU), Delhi NCR, Dadri 201314, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2321","reference":[{"key":"key-10.3934\/mbe.2023420-1","doi-asserted-by":"publisher","unstructured":"L. T. H. Phi, I. N. Sari, Y. G. Yang, S. H. Lee, N. Jun, K. S. Kim, et al., Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment, <i>Stem Cells Int.<\/i>, <b>2018<\/b> (2018), 16. https:\/\/doi.org\/10.1155\/2018\/5416923","DOI":"10.1155\/2018\/5416923"},{"key":"key-10.3934\/mbe.2023420-2","doi-asserted-by":"publisher","unstructured":"C. J. Wheeler, A. Das, G. Liu, J. S. Yu, K. L. Black, Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination, <i>Clin. Cancer Res<\/i>., <b>10<\/b> (2004), 5316\u20135326. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0497","DOI":"10.1158\/1078-0432.CCR-04-0497"},{"key":"key-10.3934\/mbe.2023420-3","doi-asserted-by":"publisher","unstructured":"R. A. Fenstermaker, M. J. Ciesielski, Immunotherapeutic strategies for malignant glioma, <i>Cancer Cont.<\/i>, <b>11<\/b> (2004), 181\u2013191. https:\/\/doi.org\/10.1177\/107327480401100306","DOI":"10.1177\/107327480401100306"},{"key":"key-10.3934\/mbe.2023420-4","doi-asserted-by":"publisher","unstructured":"P. H. Zahl, P. C. G\u00f8tzsche, J. M\u00e6hlen, Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study, <i>Lancet Oncol<\/i>., <b>12<\/b> (2011), 1118\u20131124, https:\/\/doi.org\/10.1016\/S1470-2045(11)70250-9","DOI":"10.1016\/S1470-2045(11)70250-9"},{"key":"key-10.3934\/mbe.2023420-5","doi-asserted-by":"publisher","unstructured":"D. G. Fryback, N. K. Stout, M. A. Rosenberg, A. Trentham-Dietz, V. Kuruchittham, P. L. Remington, The Wisconsin breast cancer epidemiology simulation model, <i>J. Natl. Cancer Inst. Monogr<\/i>., <b>2006<\/b> (2006), 37\u201347, https:\/\/doi.org\/10.1093\/jncimonographs\/lgj007","DOI":"10.1093\/jncimonographs\/lgj007"},{"key":"key-10.3934\/mbe.2023420-6","unstructured":"T. C. Everson, Spontaneous regression of cancer, <i>Prog. Clin. Cancer<\/i>, <b>3<\/b> (1967), 79\u201395."},{"key":"key-10.3934\/mbe.2023420-7","unstructured":"\"Spontaneous regression of cancer\" or \"Spontaneous remission of cancer\", PubMed, (2022). Available from: <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term = sponteneous+regression+of+cancer+or+sponteneous+remission+of+cancer\">https:\/\/pubmed.ncbi.nlm.nih.gov\/?term = sponteneous+regression+of+cancer+or+sponteneous+remission+of+cancer<\/ext-link>."},{"key":"key-10.3934\/mbe.2023420-8","unstructured":"H. E. Kaiser, Biological viewpoints of neoplastic regression, <i>In Vivo<\/i>, <b>8<\/b> (1994), 155\u2013165."},{"key":"key-10.3934\/mbe.2023420-9","unstructured":"M. C. Perry, D. C. Doll, C. E. Freter, <i>The Chemotherapy Sourcebook<\/i>, Lippincott Williams &amp; Wilkins, Philadelphia, 2012."},{"key":"key-10.3934\/mbe.2023420-10","doi-asserted-by":"publisher","unstructured":"D. D. Majumder, P. K. Roy, Cancer self\u2010remission and tumour instability\u2013a cybernetic analysis Towards a fresh paradigm for cancer treatment, <i>Kybernetes<\/i>, <b>29<\/b> (2000), 896\u2013927. https:\/\/doi.org\/10.1108\/03684920010342035","DOI":"10.1108\/03684920010342035"},{"key":"key-10.3934\/mbe.2023420-11","unstructured":"M. Eisen, <i>Mathematical Models in Cell Biology and Cancer Chemotherapy, Lecture Notes in Biomathematics<\/i>, Springer Berlin, Heidelberg. <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1007\/978-3-642-93126-0\">https:\/\/doi.org\/10.1007\/978-3-642-93126-0<\/ext-link>"},{"key":"key-10.3934\/mbe.2023420-12","doi-asserted-by":"publisher","unstructured":"A. J. Coldman, J. H. Goldie, A stochastic model for the origin and treatment of tumors containing drug-resistant cells, <i>Bull. Math. Biol<\/i>., <b>48<\/b> (1986), 279\u2013292. https:\/\/doi.org\/10.1007\/BF02459682","DOI":"10.1007\/BF02459682"},{"key":"key-10.3934\/mbe.2023420-13","doi-asserted-by":"publisher","unstructured":"H. E. Skipper, On mathematical modeling of critical variables in cancer treatment, <i>Bull. Math. Biol.<\/i>, <b>48<\/b> (1986), 253\u2013278. https:\/\/doi.org\/10.1007\/BF02459681","DOI":"10.1007\/BF02459681"},{"key":"key-10.3934\/mbe.2023420-14","doi-asserted-by":"publisher","unstructured":"N. Bellomo, L. Preziosi, Modelling and mathematical problems related to tumor evolution and its interaction with the immune system, <i>Math. Comput. Model.<\/i>, <b>32<\/b> (2000), 413\u2013452, https:\/\/doi.org\/10.1016\/S0895-7177(00)00143-6","DOI":"10.1016\/S0895-7177(00)00143-6"},{"key":"key-10.3934\/mbe.2023420-15","doi-asserted-by":"publisher","unstructured":"C. M. Sakode, R. Padhi, S. Kapoor, V. P. S. Rallabandi, P. K. Roy, Multimodal therapy for complete regression of malignant melanoma using constrained nonlinear optimal dynamic inversion, <i>Biomed. Signal Process. Control<\/i>, <b>13<\/b> (2014), 198\u2013211, https:\/\/doi.org\/10.1016\/j.bspc.2014.04.010","DOI":"10.1016\/j.bspc.2014.04.010"},{"key":"key-10.3934\/mbe.2023420-16","doi-asserted-by":"publisher","unstructured":"I. Osi\u0144ska, K. Popko, U. Demkow, Perforin: an important player in immune response, <i>Cent. Eur. J. Immunol.<\/i>, <b>39<\/b> (2014), 109\u2013115. https:\/\/doi.org\/10.5114\/ceji.2014.42135","DOI":"10.5114\/ceji.2014.42135"},{"key":"key-10.3934\/mbe.2023420-17","doi-asserted-by":"publisher","unstructured":"M. Bots, J. P. Medema, Granzymes at a glance, <i>J. Cell. Sci.<\/i>, <b>119<\/b> (2006), 5011\u20135014. https:\/\/doi.org\/10.1242\/jcs.03239","DOI":"10.1242\/jcs.03239"},{"key":"key-10.3934\/mbe.2023420-18","unstructured":"H. F. Lodish, A. Berk, C. A. Kaiser, C. Kaiser, M. Krieger, <i>Molecular Cell Biology<\/i>, 4th edition, Macmillan, New York, 2000."},{"key":"key-10.3934\/mbe.2023420-19","unstructured":"A. Bruce, B. Dennis, L. Julian, <i>Molecular Biology of the Cell (Second Edition)<\/i>, Garland Science, New York, (2006)."},{"key":"key-10.3934\/mbe.2023420-20","doi-asserted-by":"publisher","unstructured":"J. S. Orange, Formation and function of the lytic NK-cell immunological synapse, <i>Nat. Rev. Immunol.<\/i>, <b>8<\/b> (2008), 713\u2013725. https:\/\/doi.org\/10.1038\/nri2381","DOI":"10.1038\/nri2381"},{"key":"key-10.3934\/mbe.2023420-21","doi-asserted-by":"publisher","unstructured":"M. R. Jenkins, G. M. Griffiths, The synapse and cytolytic machinery of cytotoxic T cells, <i>Curr. Opin. Immunol.<\/i>, <b>22<\/b> (2010), 308\u2013313. https:\/\/doi.org\/10.1016\/j.coi.2010.02.008","DOI":"10.1016\/j.coi.2010.02.008"},{"key":"key-10.3934\/mbe.2023420-22","unstructured":"Spontaneous cancer regression of melanoma, PubMed, (2022). Available from: <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term = spontaneous+cancer+regression+of+melanoma\">https:\/\/pubmed.ncbi.nlm.nih.gov\/?term = spontaneous+cancer+regression+of+melanoma<\/ext-link>."},{"key":"key-10.3934\/mbe.2023420-23","doi-asserted-by":"publisher","unstructured":"K. Blessing, K. M. McLaren, Histological regression in primary cutaneous melanoma: recognition, prevalence and significance, <i>Histopathology<\/i>, <b>20<\/b> (1992), 315\u2013322. https:\/\/doi.org\/10.1111\/j.1365-2559.1992.tb00988.x","DOI":"10.1111\/j.1365-2559.1992.tb00988.x"},{"key":"key-10.3934\/mbe.2023420-24","doi-asserted-by":"publisher","unstructured":"S. Ribero, M. R. Gualano, S. Osella-Abate, Association of histologic regression in primary melanoma with sentinel lymph node status: A systematic review and meta-analysis, <i>JAMA Dermatol.<\/i>, <b>151<\/b> (2015), 1301\u20131307. https:\/\/doi.org\/10.1001\/jamadermatol.2015.2235","DOI":"10.1001\/jamadermatol.2015.2235"},{"key":"key-10.3934\/mbe.2023420-25","doi-asserted-by":"crossref","unstructured":"Editorial, Melanoma research gathers momentum, <i>Lancet<\/i>, <b>385<\/b> (2015), 2323.","DOI":"10.1016\/S0140-6736(15)61087-X"},{"key":"key-10.3934\/mbe.2023420-26","unstructured":"I. G. Vladimirova, <i>Thermodynamics of Biological Processes<\/i>, Boston: De Gruyter, Berlin, 1978. <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1515\/9783110860511-027\">https:\/\/doi.org\/10.1515\/9783110860511-027<\/ext-link>"},{"key":"key-10.3934\/mbe.2023420-27","doi-asserted-by":"publisher","unstructured":"T. Z. Biktimirov, A. A. Butov, Y. G. Savinov, Optimal control of the moment of spontaneous tumor regression, <i>Automat. Remote Cont.<\/i>, <b>66<\/b> (2005), 658\u2013663. https:\/\/doi.org\/10.1007\/s10513-005-0108-z","DOI":"10.1007\/s10513-005-0108-z"},{"key":"key-10.3934\/mbe.2023420-28","doi-asserted-by":"publisher","unstructured":"N. Kondo, A. Takahashi, K. Ono, DNA damage induced by alkylating agents and repair pathways, <i>J. Nucleic Acids<\/i>, <b>2010<\/b> (2010). https:\/\/doi.org\/10.4061\/2010\/543531","DOI":"10.4061\/2010\/543531"},{"key":"key-10.3934\/mbe.2023420-29","doi-asserted-by":"publisher","unstructured":"E. C. Friedberg, L. D. McDaniel, R. A. Schultz, The role of endogenous and exogenous DNA damage and mutagenesis, <i>Curr. Opin Genet. Dev.<\/i>, <b>14<\/b> (2004), 5\u201310. https:\/\/doi.org\/10.1016\/j.gde.2003.11.001","DOI":"10.1016\/j.gde.2003.11.001"},{"key":"key-10.3934\/mbe.2023420-30","doi-asserted-by":"publisher","unstructured":"G. P. Dunn, A. T. Bruce, H. Ikeda, L. J. Old, R. D. Schreiber, Cancer immunoediting: from immunosurveillance to tumor escape, <i>Nat. Immunol.<\/i>, <b>3<\/b> (2002), 991\u2013998. https:\/\/doi.org\/10.1038\/ni1102-991","DOI":"10.1038\/ni1102-991"},{"key":"key-10.3934\/mbe.2023420-31","doi-asserted-by":"publisher","unstructured":"G. P. Dunn, L. J. Old, R. D. Schreiber, The immunobiology of cancer immunosurveillance and immunoediting, <i>Immunity<\/i>, <b>21<\/b> (2004), 137\u2013148. https:\/\/doi.org\/10.1016\/j.immuni.2004.07.017","DOI":"10.1016\/j.immuni.2004.07.017"},{"key":"key-10.3934\/mbe.2023420-32","doi-asserted-by":"publisher","unstructured":"M. Ewend, R. Thompson, R. Anderson, A. K. Sills, K. Staveley-O'Carroll, B. M. Tyler, et al., Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system, <i>J. Immunother.<\/i>, <b>2<\/b> (2000), 435\u2013448. https:\/\/doi.org\/10.1097\/00002371-200007000-00007","DOI":"10.1097\/00002371-200007000-00007"},{"key":"key-10.3934\/mbe.2023420-33","doi-asserted-by":"publisher","unstructured":"L. G. de Pillis, W. Gu, A. E. Radunskaya, Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations, <i>J. Theor. Biol.<\/i>, <b>238<\/b> (2006), 841\u2013862, https:\/\/doi.org\/10.1016\/j.jtbi.2005.06.037","DOI":"10.1016\/j.jtbi.2005.06.037"},{"key":"key-10.3934\/mbe.2023420-34","doi-asserted-by":"publisher","unstructured":"V. A. Kuznetsov, I. L. Makalkin, M. A. Taylor, A. S. Perelson, Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis, <i>Bull. Math. Biol.<\/i>, <b>56<\/b> (1994), 295\u2013321. https:\/\/doi.org\/10.1007\/BF02460644","DOI":"10.1007\/BF02460644"},{"key":"key-10.3934\/mbe.2023420-35","doi-asserted-by":"publisher","unstructured":"D. Kirschner, J. C. Panetta, Modeling immunotherapy of the tumor-immune interaction. <i>J. Math. Biol.<\/i>, <b>37<\/b> (1998), 235\u2013252, https:\/\/doi.org\/10.1007\/s002850050127","DOI":"10.1007\/s002850050127"},{"key":"key-10.3934\/mbe.2023420-36","doi-asserted-by":"publisher","unstructured":"L. G. de Pillis, A. E. Radunskaya, C. L. Wiseman, A validated mathematical model of cell-mediated immune response to tumor growth, <i>Cancer Res.<\/i>, <b>65<\/b> (2005), 7950\u20137958, https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0564","DOI":"10.1158\/0008-5472.CAN-05-0564"},{"key":"key-10.3934\/mbe.2023420-37","doi-asserted-by":"publisher","unstructured":"P. K. Roy, R. Kozma, D. D. Majumder, From neurocomputation to immunocomputation-a model and algorithm for fluctuation-induced instability and phase transition in biological systems, <i>IEEE Trans. Evol. Comput.<\/i>, <b>6<\/b> (2002), 292\u2013305, https:\/\/doi.org\/10.1109\/TEVC.2002.1011542","DOI":"10.1109\/TEVC.2002.1011542"},{"key":"key-10.3934\/mbe.2023420-38","doi-asserted-by":"publisher","unstructured":"S. Singh, R. Padhi, Automatic path planning and control design for autonomous landing of UAVs using dynamic inversion, <i>Am. Control Conf.<\/i>, <b>2009<\/b> (2009), 2409\u20132414. https:\/\/doi.org\/10.1109\/ACC.2009.5160444","DOI":"10.1109\/ACC.2009.5160444"},{"key":"key-10.3934\/mbe.2023420-39","unstructured":"H. Khalil, Nonlinear Systems, 2th edition, in Prentice-Hall, New Jersey, 1996."},{"key":"key-10.3934\/mbe.2023420-40","doi-asserted-by":"publisher","unstructured":"S. Nanda, H. Moore, S. Lenhart, Optimal control of treatment in a mathematical model of chronic myelogenous leukemia, <i>Math. Biosci.<\/i>, <b>210<\/b> (2007), 143\u2013156, https:\/\/doi.org\/10.1016\/j.mbs.2007.05.003","DOI":"10.1016\/j.mbs.2007.05.003"},{"key":"key-10.3934\/mbe.2023420-41","doi-asserted-by":"publisher","unstructured":"F. Rambow, G. Piton, S. Bouet, J. J. Leplat, S. Baulande, A. Marrau, et al., Gene expression signature for spontaneous cancer regression in melanoma pigs, <i>Neoplasia<\/i>, <b>10<\/b> (2008), 714\u2013726, https:\/\/doi.org\/10.1593\/neo.08344","DOI":"10.1593\/neo.08344"},{"key":"key-10.3934\/mbe.2023420-42","unstructured":"Analyze your own microarray data in R\/Bioconductor-BITS wiki., 2022. Available from: <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/wiki.bits.vib.be\/index.php\/Analyze_your_own_microarray_data_in_R\/Bioconductor\">https:\/\/wiki.bits.vib.be\/index.php\/Analyze_your_own_microarray_data_in_R\/Bioconductor<\/ext-link>."},{"key":"key-10.3934\/mbe.2023420-43","doi-asserted-by":"publisher","unstructured":"D. M. Ugo, Does the cell number 10(9) still really fit one gram of tumor tissue?, <i>Cell Cycle<\/i>, <b>8<\/b> (2009), 505\u2013506. https:\/\/doi.org\/10.4161\/cc.8.3.7608","DOI":"10.4161\/cc.8.3.7608"},{"key":"key-10.3934\/mbe.2023420-44","doi-asserted-by":"publisher","unstructured":"J. Foo, F. Michor, Evolution of acquired resistance to anti-cancer therapy, <i>J. Theor. Biol.<\/i>, <b>355<\/b> (2014), 10\u201320, https:\/\/doi.org\/10.1016\/j.jtbi.2014.02.025","DOI":"10.1016\/j.jtbi.2014.02.025"},{"key":"key-10.3934\/mbe.2023420-45","doi-asserted-by":"crossref","unstructured":"A. I. Zotin, <i>Thermodynamic Bases of Biological Processes: Physiological Reactions and Adaptations<\/i>, Walter de Gruyter, Berlin, (1990). <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1515\/9783110849974\">https:\/\/doi.org\/10.1515\/9783110849974<\/ext-link>","DOI":"10.1515\/9783110849974"},{"key":"key-10.3934\/mbe.2023420-46","doi-asserted-by":"publisher","unstructured":"K. A. Smith, Interleukin-2: inception, impact, and implications, <i>Science<\/i>, <b>240<\/b> (1988), 1169\u20131176, https:\/\/doi.org\/10.1126\/science.3131876","DOI":"10.1126\/science.3131876"},{"key":"key-10.3934\/mbe.2023420-47","unstructured":"S. Ratner, <i>Mechanisms of Lymphocyte Extravasation<\/i>, 1st edition, S. Karger, Basel, 1992."},{"key":"key-10.3934\/mbe.2023420-48","doi-asserted-by":"publisher","unstructured":"I. Rousalova, E. Krepela, Granzyme B-induced apoptosis in cancer cells and its regulation. <i>Int. J. Oncol.<\/i>, <b>37<\/b> (2010), 1361\u20131378, https:\/\/doi.org\/10.3892\/ijo_00000788","DOI":"10.3892\/ijo_00000788"},{"key":"key-10.3934\/mbe.2023420-49","doi-asserted-by":"publisher","unstructured":"A. Khar., Mechanisms involved in natural killer cell mediated target cell death leading to spontaneous tumour regression, <i>J. Biosci.<\/i>, <b>22<\/b> (1997), 23\u201331, https:\/\/doi.org\/10.1007\/BF02703615","DOI":"10.1007\/BF02703615"},{"key":"key-10.3934\/mbe.2023420-50","doi-asserted-by":"publisher","unstructured":"Q. Gao, G. Zhou, S. J. Lin, R. Paus, Z. C. Yue, How chemotherapy and radiotherapy damage the tissue: Comparative biology lessons from feather and hair models, <i>Exp. Dermatol<\/i>, <b>28<\/b> (2019), 413\u2013418. https:\/\/doi.org\/10.1111\/exd.13846","DOI":"10.1111\/exd.13846"},{"key":"key-10.3934\/mbe.2023420-51","doi-asserted-by":"publisher","unstructured":"C. Yarana, D. K.St. Clair, Chemotherapy-induced tissue injury: An insight into the role of extracellular vesicles-mediated oxidative stress responses, <i>Antioxidants (Basel)<\/i>, <b>6<\/b> (2017), 75. https:\/\/doi.org\/10.3390\/antiox6040075","DOI":"10.3390\/antiox6040075"},{"key":"key-10.3934\/mbe.2023420-52","doi-asserted-by":"publisher","unstructured":"A. Z. Ayob, T. S. Ramasamy, Cancer stem cells as key drivers of tumour progression, <i>J. Biomed. Sci.<\/i>, <b>25<\/b> (2018), 20. https:\/\/doi.org\/10.1186\/s12929-018-0426-4","DOI":"10.1186\/s12929-018-0426-4"},{"key":"key-10.3934\/mbe.2023420-53","doi-asserted-by":"publisher","unstructured":"M. E. Dudley, J. R. Wunderlich, P. F. Robbins, J. C. Yang, P. Hwu, D. J. Schwartzentruber, et al., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, <i>Science<\/i>, <b>298<\/b> (2002), 850\u2013854, https:\/\/doi.org\/10.1126\/science.1076514","DOI":"10.1126\/science.1076514"},{"key":"key-10.3934\/mbe.2023420-54","doi-asserted-by":"publisher","unstructured":"M. L. Disis, H. Bernhard, E. M. Jaffee, Use of tumour-responsive T cells as cancer treatment, <i>Lancet<\/i>, <b>373<\/b> (2009), 673\u2013683. https:\/\/doi.org\/10.1016\/S0140-6736(09)60404-9","DOI":"10.1016\/S0140-6736(09)60404-9"},{"key":"key-10.3934\/mbe.2023420-55","doi-asserted-by":"publisher","unstructured":"A. Radbruch, A. Thiel, Cell therapy for autoimmune diseases: does it have a future, <i>Ann. Rheum. Dis.<\/i>, <b>63<\/b> (2004), 96\u2013101. http:\/\/dx.doi.org\/10.1136\/ard.2004.028340","DOI":"10.1136\/ard.2004.028340"},{"key":"key-10.3934\/mbe.2023420-56","doi-asserted-by":"publisher","unstructured":"N. Sengupta, T. S. MacFie, T. T. MacDonald, D. Pennington, A. R. Silver, Cancer immunoediting and \"spontaneous\" tumor regression, <i>Pathol. Res. Pract<\/i>., <b>206<\/b> (2010), 1\u20138. https:\/\/doi.org\/10.1016\/j.prp.2009.10.001","DOI":"10.1016\/j.prp.2009.10.001"},{"key":"key-10.3934\/mbe.2023420-57","doi-asserted-by":"publisher","unstructured":"R. Martin, K. L. Teo, Optimal control of drug administration in cancer chemotherapy, <i>World Sci.<\/i>, <b>1993<\/b> (1993), 204. https:\/\/doi.org\/10.1142\/2048","DOI":"10.1142\/2048"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2023420?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T13:07:32Z","timestamp":1679490452000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2023420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2023420","relation":{},"ISSN":["1551-0018"],"issn-type":[{"type":"print","value":"1551-0018"}],"subject":[],"published":{"date-parts":[[2023]]}}}